[1] |
赵文杰. 口腔癌相关危险因素的流行病学调查分析[J]. 中外健康文摘, 2013(24): 119-120.
|
[2] |
Ren M, Lotfipour S. Nicotine gateway effects on adolescent substance use[J]. West J Emerg Med, 2019, 20(5): 696-709.
doi: 10.5811/westjem.2019.7.41661
pmid: 31539325
|
[3] |
Zhao Y, Zhou W, Xue L, et al. Nicotine activates YAP1 through nAChRs mediated signaling in esophageal squamous cell cancer(ESCC)[J]. Plus ONE, 2014, 9(3):e90836.
|
[4] |
Zoli M, Pucci S, Vilella A, et al. Neuronal and extraneuronal nicotinic acetylcholine receptors[J]. Curr Neuropharmacol, 2018, 16(4): 338-349.
doi: 10.2174/1570159X15666170912110450
pmid: 28901280
|
[5] |
Wisniewski DJ, Ma T, Schneider A. Nicotine induces oral dysplastic keratinocyte migration via fatty acid synthase-dependent epidermal growth factor receptor activation[J]. Exp Cell Res, 2018, 370(2): 343-352.
doi: S0014-4827(18)30378-1
pmid: 29966661
|
[6] |
Warnakulasuriya S, Straif K. Carcinogenicity of smokeless tobacco: Evidence from studies in humans & experimental animals[J]. Indian J Med Res, 2018, 148(6): 681-686.
doi: 10.4103/ijmr.IJMR_149_18
pmid: 30778001
|
[7] |
Arredondo J, Chernyavsky AI, Marubio LM, et al. Receptor-mediated tobacco toxicity: Regulation of gene expression through alpha3beta2 nicotinic receptor in oral epithelial cells[J]. Am J Pathol, 2005, 166(2): 597-613.
doi: 10.1016/s0002-9440(10)62281-x
pmid: 15681842
|
[8] |
Salimi M, Esfahani M, Habibzadeh N, et al. Change in nicotine-induced VEGF, PGE2 and COX-2 expression following COX inhibition in human oral squamous cancer[J]. J Environ Pathol Toxicol Oncol, 2012, 31(4): 349-356.
pmid: 23394447
|
[9] |
Walz JZ, Saha J, Arora A, et al. Fatty acid synthase as a potential therapeutic target in feline oral squamous cell carcinoma[J]. Vet Comp Oncol, 2018, 16(1): E99-E108.
|
[10] |
Malik UU, Siddiqui IA, Ilyas A, et al. Identification of differentially expressed proteins from smokeless tobacco addicted patients suffering from oral squamous cell carcinoma[J]. Pathol Oncol Res, 2020, 26(3): 1489-1497.
doi: 10.1007/s12253-019-00724-y
pmid: 31446608
|
[11] |
Wang SC, Hu Y. α7 nicotinic acetylcholine receptors in lung cancer[J]. Oncol Lett, 2018, 16(2): 1375-1382.
doi: 10.3892/ol.2018.8841
pmid: 30008813
|
[12] |
Nishioka T, Tada H, Ibaragi S, et al. Nicotine exposure induces the proliferation of oral cancer cells through the α7 subunit of the nicotinic acetylcholine receptor[J]. Biochem Biophys Res Commun, 2019, 509(2): 514-520.
doi: 10.1016/j.bbrc.2018.12.154
URL
|
[13] |
Cheng WL, Chen KY, Lee KY, et al. Nicotinic-nAChR signaling mediates drug resistance in lung cancer[J]. J Cancer, 2020, 11(5): 1125-1140.
doi: 10.7150/jca.36359
URL
|
[14] |
田臻, 张伟国. 黏附机制与口腔黏膜鳞状细胞癌侵袭和转移关系的研究进展[J]. 口腔颌面外科杂志, 2001, 11(1): 53-56.
|
[15] |
Wang M, Niu WW, Qi MC, et al. Nicotine promotes cervical metastasis of oral cancer by regulating peroxiredoxin 1 and epithelial-mesenchymal transition in mice[J]. Onco Targets Ther, 2019, 12: 3327-3338.
doi: 10.2147/OTT
URL
|
[16] |
Yang SH, Lee TY, Ho CA, et al. Exposure to nicotine-derived nitrosamine ketone and arecoline synergistically facilitates tumor aggressiveness via overexpression of epidermal growth factor receptor and its downstream signaling in head and neck squamous cell carcinoma[J]. PLoS One, 2018, 13(8): e0201267.
doi: 10.1371/journal.pone.0201267
URL
|
[17] |
Nieh S, Jao SW, Yang CY, et al. Regulation of tumor progression via the Snail-RKIP signaling pathway by nicotine exposure in head and neck squamous cell carcinoma[J]. Head Neck, 2015, 37(12): 1712-1721.
doi: 10.1002/hed.v37.12
URL
|
[18] |
Niu WW, Zhang M, Chen H, et al. Peroxiredoxin 1 promotes invasion and migration by regulating epithelial-to-mesenchymal transition during oral carcinogenesis[J]. Oncotarget, 2016, 7(30): 47042-47051.
doi: 10.18632/oncotarget.9705
pmid: 27259998
|
[19] |
Sultan AS, Jessri M, Farah CS. Electronic nicotine delivery systems: Oral health implications and oral cancer risk[J]. J Oral Pathol Med, 2021, 50(3): 316-322.
doi: 10.1111/jop.v50.3
URL
|